{
    "clinical_study": {
        "@rank": "56864", 
        "arm_group": [
            {
                "arm_group_label": "KSY diluted", 
                "arm_group_type": "Placebo Comparator", 
                "description": "KSY diluted, 100mg decoction by mouth per day for 6 weeks"
            }, 
            {
                "arm_group_label": "KSY", 
                "arm_group_type": "Experimental", 
                "description": "KSY, 100mg decoction by mouth per day for 6 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on\n      HCV Carrier With Abnormal Liver Function."
        }, 
        "brief_title": "The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Liver Function", 
        "detailed_description": {
            "textblock": "percentage of change on HCV RNA titer and liver function (GPT)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  40 < GPT <200 HCV carrier Age: 18-65 yrs old\n\n        Exclusion Criteria:\n\n          -  Creatinine >2.0 mg/dL Total bilirubin > 2.0mg/dL Not suitable patients diagnosis by\n             physician in charge."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "57", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708733", 
            "org_study_id": "101001-62-010"
        }, 
        "intervention": {
            "arm_group_label": "KSY", 
            "description": "Chinese herbal formula", 
            "intervention_name": "KSY", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HCV carrier", 
            "Chinese herbal medicine", 
            "Liver function", 
            "HCV RNA titer"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "886"
                }, 
                "name": "Taipei City Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Evaluation of the Extract of KUAN SIN YIN on Hepatitis C: a Randomized, Double-blinded and Placebo-controlled Clinical Trial.", 
        "other_outcome": {
            "measure": "WHOQOL-BREF", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "HCV RNA titer", 
            "safety_issue": "Yes", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708733"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Taipei City Hospital", 
            "investigator_full_name": "Chung-Hua Hsu", 
            "investigator_title": "chief medical officer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Serum GPT level", 
            "safety_issue": "Yes", 
            "time_frame": "6 weeks"
        }, 
        "source": "Taipei City Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Taipei City Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}